iBio
Using artificial intelligence to efficiently and consistently delivers antibody candidates against difficult targets.
Launch date
Employees
Market cap
AUD25.7m
Enterprise valuation
AUD44m (Public information from Sep 2024)
Share price
$1.9 IBIO
Newark New Jersey (HQ)
Authorizing premium user...